Related Experiment Video
Updated: Dec 8, 2025

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction
Chongkui Sun1, Kun Wang1, Amanda J Stock1
1Biomedical Research Center, National Institute on Aging/National Institutes of Health, Baltimore, MD, USA.
Abstract:
Short telomeres are a principal defining feature of telomere biology disorders, such as dyskeratosis congenita (DC), for which there are no effective treatments. Here, we report that primary fibroblasts from DC patients and late generation telomerase knockout mice display lower nicotinamide adenine dinucleotide (NAD) levels, and an imbalance in the NAD metabolome that includes elevated CD38 NADase and reduced poly(ADP-ribose) polymerase and SIRT1 activities, respectively, affecting many associated biological pathways. Supplementation with the NAD precursor, nicotinamide riboside, and CD38 inhibition improved NAD homeostasis, thereby alleviating telomere damage, defective mitochondrial biosynthesis and clearance, cell growth retardation, and cellular senescence of DC fibroblasts. These findings reveal a direct, underlying role of NAD dysregulation when telomeres are short and underscore its relevance to the pathophysiology and interventions of human telomere-driven diseases.
Insights
Short telomeres in telomere biology disorders are linked to low nicotinamide adenine dinucleotide (NAD) levels. Restoring NAD homeostasis with precursors or CD38 inhibition improved cell health and alleviated damage in related diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Genetics
Background:
- Short telomeres characterize telomere biology disorders like dyskeratosis congenita (DC).
- Currently, no effective treatments exist for DC.
- Telomere dysfunction impacts cellular health and organismal aging.
Purpose of the Study:
- To investigate the role of nicotinamide adenine dinucleotide (NAD) metabolism in telomere biology disorders.
- To explore therapeutic interventions targeting NAD homeostasis in DC.
Main Methods:
- Analysis of NAD levels and metabolome in DC patient fibroblasts and telomerase knockout mice.
- Assessment of CD38 NADase, poly(ADP-ribose) polymerase, and SIRT1 activities.
- Evaluation of therapeutic effects of NAD precursor (nicotinamide riboside) and CD38 inhibition.
Main Results:
- DC fibroblasts and telomerase knockout mice showed reduced NAD levels and altered NAD metabolome.
- Elevated CD38 NADase and reduced poly(ADP-ribose) polymerase and SIRT1 activities were observed.
- Supplementation with nicotinamide riboside and CD38 inhibition restored NAD homeostasis, alleviating telomere damage, mitochondrial dysfunction, and senescence.
Conclusions:
- NAD dysregulation is a key factor in the pathophysiology of short telomere diseases.
- Targeting NAD metabolism offers a potential therapeutic strategy for telomere biology disorders.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Homeostatic Imbalance
However, sometimes these feedback loops fail,...
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replicative Cell Senescence
Regulation of Metabolism

